T1	Treatment 14 58	prophylactic calcium and magnesium infusions
T2	Treatment 805 917	treatment with capecitabine, oxaliplatin and bevacizumab or the same combination with the addition of cetuximab.
T3	Treatment 961 1107	two groups: patients in the Ca/Mg(+) group received Ca/Mg at least during their first treatment cycle, and patients in the Ca/Mg(-) group did not.
T4	Treatment 1857 1871	neurotoxicity.
T5	Treatment 1872 1887	Ca/Mg infusions
